Kizilkaya, B., Cure, O. and Durak, S. (2025) “Risk of hepatitis B reactivation in rheumatic patients receiving tocilizumab treatment”, Annals of Medical Research, 32(11), pp. 512–517. Available at: http://www.annalsmedres.org/index.php/aomr/article/view/4880 (Accessed: 14 September 2026).